These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 1676368

  • 1. Comparison of the antihypertensive and renal effects of tertatolol and nadolol in hypertensive patients with mild renal impairment.
    Fallo F, Gregianin M, Bui F, Macrì C, Folino P, Mantero F.
    Eur J Clin Pharmacol; 1991; 40(3):309-11. PubMed ID: 1676368
    [Abstract] [Full Text] [Related]

  • 2. Acute effects of tertatolol and nadolol on systemic and renal hemodynamics in patients with essential hypertension.
    Degaute JP, Naeije R, Abramowicz M, Leeman M, Schoutens A, Prost JF.
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):263S-268S. PubMed ID: 3415803
    [Abstract] [Full Text] [Related]

  • 3. Alterations in renal hemodynamics during chronic and acute beta-blockade in humans.
    Beaufils M.
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):233S-236S. PubMed ID: 2573369
    [Abstract] [Full Text] [Related]

  • 4. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A.
    Branten AJ, Hilbrands LB, van Hamersvelt HW, Koene RA, Huysmans FT.
    Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456
    [Abstract] [Full Text] [Related]

  • 5. Comparison between short-term renal haemodynamic effects of propranolol and nadolol in essential hypertension: a cross-over study.
    Danesh BJ, Brunton J, Sumner DJ.
    Clin Sci (Lond); 1984 Aug; 67(2):243-8. PubMed ID: 6146425
    [Abstract] [Full Text] [Related]

  • 6. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.
    Dupont AG, Vanderniepen P, Bossuyt AM, Jonckheer MH, Six RO.
    Br J Clin Pharmacol; 1985 Aug; 20(2):93-9. PubMed ID: 2864051
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG, Laher MS, McGarry K, O'Brien E, O'Malley K.
    Br J Clin Pharmacol; 1983 Oct; 16(4):417-21. PubMed ID: 6138058
    [Abstract] [Full Text] [Related]

  • 8. Overview of novel renal properties of tertatolol.
    Guillet C.
    Cardiology; 1993 Oct; 83 Suppl 1():64-9. PubMed ID: 7903218
    [Abstract] [Full Text] [Related]

  • 9. Chronic effects of tertatolol on renal function in hypertensive patients with mild chronic renal failure.
    Hannedouche T, Brouard R, Godin M, Kleinknecht D, Paillard F, Grünfeld JP.
    Nephrol Dial Transplant; 1991 Oct; 6(4):252-6. PubMed ID: 1679214
    [Abstract] [Full Text] [Related]

  • 10. [Renal effects of intravenous tertatolol in essential arterial hypertension].
    Chaignon M, Brouard R, Lucsko M, Guédon J.
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1219-22. PubMed ID: 1979729
    [Abstract] [Full Text] [Related]

  • 11. Renal hemodynamic effects of tertatolol in essential hypertension.
    Paillard F, Lantz B, Leviel F, Ardaillou R.
    Am J Nephrol; 1986 Jul; 6 Suppl 2():40-4. PubMed ID: 2879472
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A, Leonetti G, Bernini GP, Rupoli L, Lucarini AR, Sangiorgio P, Mauro M, Di Stratis P, Zanchetti A.
    Am J Nephrol; 1986 Jul; 6 Suppl 2():45-9. PubMed ID: 2879473
    [Abstract] [Full Text] [Related]

  • 13. A comparison of betaxolol and nadolol on renal function in essential hypertension.
    Bauer JH, Reams GP, Lau A.
    Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M, Prost JF, Rochat C.
    Am J Nephrol; 1986 Aug; 6 Suppl 2():20-4. PubMed ID: 2879468
    [Abstract] [Full Text] [Related]

  • 18. Preserving the autoregulation of renal hemodynamics.
    Beaufils M.
    Cardiology; 1993 Aug; 83 Suppl 1():10-5. PubMed ID: 7903210
    [Abstract] [Full Text] [Related]

  • 19. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
    O'Connor DT, Barg AP, Duchin KL.
    J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
    [Abstract] [Full Text] [Related]

  • 20. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED, Messerli FH, Deslinski GR, Kobrin I.
    Am Heart J; 1984 Oct; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.